CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir

Roger Badia, Ester Ballana, Marc Castellví, Edurne García-Vidal, Maria Pujantell, Bonaventura Clotet, Julia G. Prado, Jordi Puig, Miguel A. Martínez, Eva Riveira-Muñoz () and José A. Esté ()
Additional contact information
Roger Badia: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
Ester Ballana: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
Marc Castellví: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
Edurne García-Vidal: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
Maria Pujantell: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
Bonaventura Clotet: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
Julia G. Prado: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
Jordi Puig: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
Miguel A. Martínez: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
Eva Riveira-Muñoz: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona
José A. Esté: Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona

Nature Communications, 2018, vol. 9, issue 1, 1-10

Abstract: Abstract CD32 has been shown to be preferentially expressed in latently HIV-1-infected cells in an in vitro model of quiescent CD4 T cells. Here we show that stimulation of CD4+ T cells with IL-2, IL-7, PHA, and anti-CD3/CD28 antibodies induces T-cell proliferation, co-expression of CD32 and the activation of the markers HLA-DR and CD69. HIV-1 infection increases CD32 expression. 79.2% of the CD32+/CD4+ T cells from HIV+ individuals under antiretroviral treatment were HLA-DR+. Resting CD4+ T cells infected in vitro generally results in higher integration of provirus. We observe no difference in provirus integration or replication-competent inducible latent HIV-1 in CD32+ or CD32− CD4+ T cells from HIV+ individuals. Our results demonstrate that CD32 expression is a marker of CD4+ T cell activation in HIV+ individuals and raises questions regarding the immune resting status of CD32+ cells harboring HIV-1 proviruses.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-018-05157-w Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05157-w

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-018-05157-w

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().